论文部分内容阅读
目的观察参麦注射液早期辅助治疗结核性胸腔积液疗效。方法将2007-09-2009-11住院治疗的结核性胸腔积液患者120例随机分为实验组(60例)和对照组(60例)。实验组在抗结核化疗和胸穿置管术的基础上加用参麦注射液治疗,两组抗结核化疗方案相同,时间为1个月。结果实验组治愈率高于对照组,形成胸膜肥厚、粘连和包裹、分隔均低于对照组,实验组药物性肝损害的发生率低于对照组,均有统计学意义。结论参麦注射液对结核性胸腔积液的近期治疗有良好的辅助作用。
Objective To observe the effect of Shenmai injection in the early adjuvant treatment of tuberculous pleural effusion. Methods 120 patients with tuberculous pleural effusion admitted to hospital from September 2007 to September 2009 were randomly divided into experimental group (60 cases) and control group (60 cases). The experimental group was treated with Shenmai injection on the basis of anti-tuberculosis chemotherapy and thoracotomy, and the two anti-tuberculosis chemotherapy regimens were the same for one month. Results The cure rate of the experimental group was higher than that of the control group, forming pleural hypertrophy, adhesions and parcels, the separation was lower than the control group, and the incidence of drug-induced liver damage in the experimental group was lower than that of the control group, both of which were statistically significant. Conclusion Shenmai injection has a good adjuvant effect on the recent treatment of tuberculous pleural effusion.